RaySearch Laboratories AB (publ) Interim Report January 1 -

RaySearch Laboratories AB (publ) Interim Report January 1 - September
30, 2010

JANUARY 1 - SEPTEMBER 30, 2010

  · Net sales for the period totaled SEK 83.0 M (47.3)
  · Operating profit totaled SEK 24.5 M (17.1)
  · Profit after tax amounted to SEK 17.5 M (12.6) and earnings per
share to SEK 0.51 (0.37)
  · Cash flow was a negative SEK 2.8 M (pos: 5.4)
  · RaySearch received FDA approval for RayStation® in the US in March
  · The collaboration agreement with Varian was expanded in April 

EVENTS AFTER THE END OF THE PERIOD 

  · Breakthrough RayStation® order from Massachusetts General Hospital
was received in October 

 

“The first nine months of the year was a successful period, and with the
order from Massachusetts General Hospital in October, we reached a very
important strategic milestone for RaySearch. The order means that
Massachusetts General Hospital will be the first hospital in the world
to use RayStation® and our solution for multi-criteria optimization in
clinical practice”, says Johan Löf, CEO of RaySearch. 

“January to September was also a strong period financially for RaySearch
and the number of licenses sold almost doubled. The volume growth was
primarily attributable to a positive reception to all of the new
products launched in late 2009”, concludes Johan Löf. 

 

FOR FURTHER INFORMATION, PLEASE CONTACT: 

Johan Löf, CEO
Telephone: +46 (0)8-545 061 30
johan.lof@raysearchlabs.com (johan.lof@raysearchlabs.com) 

 

ABOUT RAYSEARCH
RaySearch Laboratories is a medical technology company that develops
advanced software solutions for improved radiation therapy of cancer.
RaySearch's products are mainly sold through license agreements with
leading partners such as Philips, Varian, Siemens, Nucletron, IBA
Dosimetry and TomoTherapy. To date, 15 products have been launched
through partners and RaySearch's software is used at some 1,500 clinics
in more than 30 countries. In addition, existing license agreements
cover more than 15 other products that are scheduled to be launched in
the coming years. RaySearch was founded in 2000 as a spin-off from
Karolinska Institutet in Stockholm and the company is listed on the
Small Cap segment on NASDAQ OMX Stockholm. 

More information about RaySearch is available at:
www.raysearchlabs.com (http://www.raysearchlabs.com/).
RaySearch Laboratories AB (publ) Interim Report January 1 - September 30, 2010

Attachments
